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Although previous studies have shown associations between patient symptoms/outcomes and the 
spontaneous tympanic membrane displacement (spTMD) pulse amplitude, the contribution of the 
underlying intracranial pressure (ICP) signal to the spTMD pulse remains largely unknown. We have 
assessed the relative contributions of ICP and arterial blood pressure (ABP) on spTMD at different 
frequencies in order to determine whether spTMD contains information about the ICP above and 
beyond that contained in the ABP. 
Approach 
Eleven patients, who all had invasive ICP and ABP measurements in-situ, were recruited from our 
intensive care unit. Their spTMD was recorded and the power spectral densities of the 3 signals, as 
well as coherences between the signals, were calculated in the range 0.1 – 5 Hz. Simple and multiple 
coherences, coupled with statistical tests using surrogate data, were carried out to quantify the 
relative contributions of ABP and ICP to spTMD. 
Main results 
Most power of the signals was found to predominate at respiration rate, heart rate, and their 
harmonics, with little outside of these frequencies. Analysis of the simple coherences found a slight 
preference for ICP transmission, beyond that from ABP, to the spTMD at lower frequencies (7/11 
patients at respiration, 7/10 patients at respiration 1st harmonic) which is reversed at the higher 
frequencies (2/11 patients at heart rate and its 1st harmonic). Both ICP and ABP were found to 
independently contribute to the spTMD. The multiple coherence reinforced that ICP is preferentially 
being transmitted at respiration and respiration 1st harmonic. 
Significance 
Both ABP and ICP contribute independently to the spTMD signal, with most power occurring at clear 
physiological frequencies – respiration and harmonics and heart rate and harmonics. There is 
information shared between the ICP and spTMD that is not present in ABP. This analysis has 




Intracranial pressure (ICP) arises due to cerebrospinal fluid (CSF), brain tissue, and circulating 
cerebral blood, co-existing within a rigid enclosed space – the skull. The Monroe-Kellie hypothesis 
thus states that any increase in one of these elements must be compensated by a decrease in 
another element or a rise in ICP (Mokri, 2001). Abnormal ICP is symptomatic of an underlying 
pathology such as subarachnoid haemorrhage, stroke, or encephalitis (Czosnyka and Pickard, 2004, 
Dunn, 2002). Current “gold standard” ICP monitoring methods are highly invasive procedures, 
requiring access to the ventricles or the brain parenchyma (Kirkman and Smith, 2014, Lundberg, 
1960). Due to the invasiveness of the procedure, complications can arise, with the risk of infection 
(Ghajar, 1995), as well as the potential for haematoma formation, and seizures (Dunn, 2002). 
Invasive ICP monitoring is only used in conditions where symptoms are severe and there is a need 
for immediate intervention. Having non-invasive measurements would allow for the screening and 
diagnosis of patients before symptoms become severe, or for monitoring the natural course and 
response to treatment of chronic conditions, allowing for better directed intervention to improve 
outcomes. 
As a result of this need, a variety of non-invasive ICP measurement techniques have been developed 
to help alleviate the difficulties associated with invasive monitoring. These include, but are not 
limited to, magnetic resonance imaging (Alperin et al., 2000), transcranial Doppler examination 
(Schoser et al., 1999), and tympanic membrane displacement (TMD) (Marchbanks, 1989). A review 
of current non-invasive ICP monitoring methods can be found in (Zhang et al., 2017). The TMD 
technique utilises the direct channel of communication (via the cochlear aqueduct) between the 
subarachnoid space in the brain and the perilymphatic fluid in the cochlea (Traboulsi and Avan, 
2007). This allows ICP changes to be transmitted through the oval window, observed as 
displacements of the tympanic membrane, and measured as volume changes in the ear canal. These 
nanolitre changes are detected through the TMD analyzer (Reid et al., 1990, Samuel et al., 1998). 
There are two forms of TMD measurements: firstly, the evoked measurement, where a 1kHz sound 
at 20 dB  above the acoustic reflex threshold is used to activate the stapedial reflex (Phillips and 
Marchbanks, 1989). Studies have shown a significant correlation between evoked TMD and direct 
ICP measurements (Gwer et al., 2013, Samuel et al., 1998), although there is large inter-subject 
variability (Shimbles et al., 2005). Despite this, the method has shown promise to diagnose 
abnormalities and measure changes within an individual over time (Konradsson et al., 2000, Moss et 
al., 1991). The second form is the spontaneous measurement, where the TMD analyzer measures 
the spontaneous volume displacement of the tympanic membrane that arises from the pulsing of 
ICP and/or arterial blood pressure (ABP) (Gwer et al., 2015, Lehrer et al., 2009).  
Gopen et al. (Gopen et al., 1997) calculated that the cochlear aqueduct acts as a low-pass filter 
transmitting the ICP signal at frequencies below 20 Hz. Thus ICP changes at frequencies as high as 
20Hz may be expected in the perilymphatic pressure, from where they will be transmitted to the 
tympanic membrane. It is likely that other pathways, such as pulsations in the outer or middle ear, in 
addition to ICP transmission through the cochlear aqueduct, contribute to the forces acting on the 
tympanic membrane. As a result, the spontaneous TMD (spTMD) is assumed to be a superposition of 
the ICP waveform with the ABP waveform, although venous pressure and respiration may also affect 
the tympanic membrane displacement. The exact interactions and relative magnitudes of the 
various physiological signals are not well understood (Finch et al., 2018). A major benefit of spTMD 
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would be realised if it is able to indirectly measure the ICP waveform rather than only its mean 
value; the former may be more important than static ICP in a diagnostic setting (Eide and Kerty, 
2011). Gwer et al. (Gwer et al., 2015) demonstrated that increased spTMD pulse measurements 
correlated with risk of death in children, whilst Lehrer et al. (Lehrer et al., 2009) analysed a number 
of patient case studies demonstrating a “clear association between symptoms and neuro-otological 
disorders that cause increased intra-aural pressure waves as recorded by the [spTMD]”. Similarly, 
Shulman et al. (Shulman et al., 2012) found that a smaller spTMD pulse correlated with improved 
symptoms after treatment of patients with neuro-otological conditions. Despite these studies, the 
contribution of the underlying ICP signal on the spTMD waveform remains largely unknown, along 
with the pathways through which variations in ABP and respiration are transmitted to the spTMD.  
Therefore, the aim of this paper is to elucidate the contributions of the ICP and ABP waveforms on 
the spTMD signal. A particular challenge exists in separating the contributions of ICP and ABP on the 
spTMD due to the fact that the ABP affects both the ICP and spTMD signals – a schematic of the 
assumed pathways is shown in Fig. 1. Our approach is to determine whether the spTMD waveform 
contains information about the ICP above and beyond the information contained in the ABP 
waveform at these frequencies.  
 
Figure 1 Transmission pathways between the three signals: arterial blood pressure (ABP), 
intracranial pressure (ICP), and spontaneous tympanic membrane displacement (spTMD). 
Throughout the paper, the assumed pathways are referred to as ‘ABP to ICP’, ‘ABP to spTMD’, and 
‘ICP to spTMD’. 
5 
 
2. Materials and Methods 
2.1 Patient Population 
The study data was collected under the approval of two National Health Service, Research ethics 
committees, ref: 14/SC/0301 and 05/Q1704/108. Data was collected over a 22 month period. 
Patients with invasive monitoring of ICP as part of their clinical management were recruited from 
our neurosurgical wards or intensive care unit. All patients with invasive ICP monitoring in place 
were eligible unless they were younger than 4 years old, older than 75 years old or if neither ear 
could be used due to trauma, wax or otitis media. Data was collected in a single visit to the patient’s 
bedside lasting approximately between 1 and 2 hours. Consent was obtained from the patient or, if 
the patient lacked capacity, following consultation with a close relative or friend. 
2.2 Data Acquisition 
Otoscopy was carried out in both ears. Further measurements were only performed if the ear was 
seen to be intact and the ear canal was not occluded by blood or wax. Tympanometry was carried 
out in both ears using a GSI Tympstar Middle Ear Analyser V2 (Grason Stadler). One ear was then 
chosen for spTMD monitoring; if a marked asymmetry was seen in the tympanometry results, then 
the ear with the closest to normal middle ear function was chosen. Otherwise the selection of which 
ear to use was based on the practicalities of patient position at the time of the measurements. The 
patients’ bed angle and pillow arrangement was not altered for the study. Awake patients were 
asked to lie still in a comfortable position; unconscious patients were not moved unless a turn was 
required to give access to the chosen ear. The MMS-14 Cerebral and Cochlear Fluid Pressure (CCFP) 
analyser (Marchbanks Measurement Systems Ltd., Lymington, UK) was then used to record 
spontaneous tympanic membrane displacements from the chosen ear. Multiple recordings, typically 
of 20 – 30 seconds duration, were made with a 4 second interval between them. These duration 
lengths were chosen as this is a typical maximum length of continuous data that may be collected 
before the inherent drift in baseline value reaches the limits of the MMS-14 device’s dynamic range. 
If the baseline drift was seen to be smaller than usual, allowing longer duration continuous 
recordings to be made, then the length of individual recordings was extended up to a maximum of 
60 seconds. This quasi continuous data collection (with a periodic 4 second pause to reset the 
baseline) was continued for as long as was practical before movement of the patient was required. 
Collected data ranged between 1 hour and 2 hours 15 minutes long, with an average recording of 1 
hour 35 minutes. 
 
The MMS-14 analogue output signal was recorded together with the invasive ICP and ABP. Data 
were sampled at 200 Hz with proprietary data acquisition software (ICM+, Cambridge Enterprise, 
Cambridge, UK, http://www.neurosurg.cam.ac.uk/icmplus) and stored for subsequent analysis.  The 
ICP measurement in clinical use at the time was used in the study and these were different for 
different patients, as follows:- i) an external pressure transducer (Truwave, Edwards Lifesciences, 
Irvine, US) within the external ventricular drainage system when the drain is closed, ii) A fibreoptic 
catheter-tip pressure transducer, intraventricular or intraparenchymal,  (Integra Camino  Plainsboro, 
US) or iii) A strain gauge catheter-tip pressure transducer, intraventricular or intraparenchymal, 
(Raumedic, Helmbrechts, Germany.) Arterial blood pressure was measured invasively via a fluid filled 
catheter in the radial artery (Truwave, Edwards Lifesciences, Irvine, US). All of the invasive pressure 
transducers used had flat frequency responses across the range of frequencies investigated and a 
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low pass filter cut-off that was significantly higher than the 40Hz filters used in the monitoring 
systems, and the maximum frequency of interest. Fluid filled systems were set-up following the 
manufacturers’ guidelines and are therefore not expected to degrade the frequency response 
characteristics of the pressure monitoring at frequencies lower than 10Hz. When available the 
patient’s ICP and ABP were recorded as digital signals directly from the patient monitoring system 
(GE CarescapeB850, GE Healthcare, Chicago, US). In patients who were not being monitored in this 
way (ward patients) their ICP and ABP were recorded as analogue signals directly from the recording 
device. All analogue signals were recorded with ICM+ using an A-D converter DT9804-16SE-BNC 
(Data Translation, Bietigheim-Bissingen, Germany). 
 
2.3 Data Processing 
The spTMD, ABP, and ICP signals of each of the patients were passed through a 2nd order 
Butterworth filter with a 20 Hz cut-off frequency; the signals then being decimated to a frequency of 
50 Hz. The frequency response of the MMS-14 CCFP behaves as a low pass filter with a 3dB 
attenuation point at approximately 9 Hz. In the current study, the frequency range of interest is 
between 0.1 – 5 Hz relating to the respiration frequency, heart rate, and their 1st harmonics. The 
upper frequency limit of 5 Hz is chosen such that the frequency response is well below the 3 dB 
point of the analyser. The limited duration of epochs, together with the drift in the signal, imposes 
the low-frequency limit of 0.1 Hz on the analysis. The epochs included in the analysis vary in length 
from 18 – 60 seconds although the majority are between 25 and 30 seconds. The linear trend in the 
spTMD (mainly due to drift in the signal) was removed from all recorded epochs prior to further 
analysis, and thus all epochs also had a mean value of zero. The ABP and ICP signals are DC shifted to 
a zero mean, since only dynamic changes are of interest in this study. 
2.4 Frequency Domain Analysis 
Power spectral densities (PSDs) are used to identify where the majority of power lies in the signals, 
and hence identify the frequencies of interest. Simple (pair-wise) coherence was used to confirm 
that spectral peaks in spTMD are indeed correlated with (and considering the physiology presumably 
driven by) ABP and ICP oscillations. Multiple coherence was then used to assess the joint and 
independent contributions of ABP and ICP to spTMD. The significance of additional contributions of 
ABP over and above that from ICP (and vice versa) was assessed by surrogate data (Monte Carlo) 
analysis.  
In order to estimate PSD and coherence, overlapped windows 18 seconds in length are chosen; in 
longer epochs, multiple overlapped 18 second windows are applied. This allows for the same 
resolution to be used for all patients, giving a spectral resolution of approximately 0.06 Hz (and 
hence a lowest frequency of 0.06 Hz in the analysis), and allows spectral and coherence peaks due to 
respiration, heart rate, and their harmonics to be clearly identified and compared between patients. 
Coherence functions are calculated on the raw signals, between ABP and ICP, ABP and spTMD, and 
ICP and spTMD. It should be noted that these coherence estimates do not take causality between 
the signals into account and hence do not distinguish between what is an input and an output. Due 
to device limitations and the resultant uncertainty about the delay between recorded signals, 
analysis of causal relations (e.g. via Granger causality analysis and directed coherence) was not 
deemed reliable. A Wilcoxon signed-rank test is used to determine whether there is a significant 
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difference in the coherences between the two transmission pathways of interest – ABP to spTMD 
and ICP to spTMD. This is done at each relevant frequency – respiration fundamental, respiration 1st 
harmonic, heart rate fundamental, and heart rate 1st harmonic. Results were deemed significant at   
= 0.05. 
Multiple coherence, with ABP and ICP as inputs and spTMD as an output, is also calculated, using the 
same overlapped windowing as for the simple coherences. In order to determine the significance of 
these coherence estimates, surrogate data analysis (Monte Carlo simulation) is performed, using 
random phase for each of the signals (Faes et al., 2004) – in each of the subjects – in turn, with 500 
repeats to build up a distribution of coherence values under three different null-hypotheses. Firstly, 
for the null-hypothesis that spTMD is not correlated with ICP and ABP, spTMD phase is randomized, 
its coherence estimated, and this process is repeated 500 times. The resulting distribution is then 
used to test for statistical significance of the multiple coherence estimates. If the multiple coherence 
from the recorded signal exceeded the 95th percentile of the null distribution, the multiple 
coherence estimate is deemed significantly greater than zero. Secondly, for the null hypothesis that 
ABP does not independently contribute to spTMD, ABP phase is randomized to give an estimate of 
the null-distribution of multiple coherence. If the multiple coherence from the recorded signal 
exceeded the 95th percentile of the null distribution, ABP was deemed to provide a significant 
additional contribution (beyond that from ICP) to spTMD. The third hypothesis was that ICP provided 
no significant additional contribution to spTMD. To test this, the ICP phase is randomized and the 
equivalent procedure used for the second hypothesis followed.  Of particular interest in this analysis 
is whether, in different frequency bands, spTMD should be considered as driven predominantly by 
ABP or ICP or both signals. The surrogate data analysis method, rather than more conventional 
statistical approaches, was chosen for two reasons: firstly, the work of Faes et al. (Faes et al., 2004) 
demonstrated that in signals with narrow-band oscillations, critical values for coherence can vary 
across the spectrum, whereas conventional estimators of the critical values give these as being 
constant e.g. (Benignus, 1969). Secondly, the estimates are made from overlapping and non-
overlapping windows (depending on the length of epochs included), which would make it very 
difficult to estimate the correct degrees of freedom needed in finding critical values by conventional 
approaches.   
 
3. Results 
3.1 Patient Population 
Eleven patients were recruited, 8 male and 3 female, with a mean age of 45 (range 17 – 73). 
Characteristics of each patient are shown in Table 1. Ten of the eleven patients were ventilated and 
sedated. Both parenchymal and extra ventricular drain (EVD) transducers were used to measure the 
ICP; EVD’s were always clamped while ICP was being measured. The average middle ear pressure 




Patient Condition Mean ICP 
(mmHg) 
ICP Transducer Mean ABP 
(mmHg) 
Ventilated 
1 TBI 16 Parenchymal 84 YES 
2 Tumour 6 EVD  102 YES 
3 TBI 12 Parenchymal 98 YES 
4 TBI 18 EVD 90 YES 
5 TBI 13 Parenchymal 90 YES 
6 TBI 16 Parenchymal 90 YES 
7 TBI 12 Parenchymal 86 YES 
8 TBI 16 EVD 88 YES 
9 Infection 9 EVD 90 YES 
10 SAH 15 EVD 100 NO 
11 SAH 6 EVD 95 YES 
Table 1 Characteristics of the 11 patients used in this study. TBI – traumatic brain injury, SAH – 
subarachnoid haemorrhage, EVD – external ventricular drain. 
3.2 Patient Data 
Two examples of the recordings are given in Fig. 2. Via visual inspection it is evident that the heart 
rate appears in both the ICP and spTMD signals. In addition to this, the respiratory frequency also 
appears to be modulating the three signals (especially apparent in patient 5). As expected, the 
morphology of ABP is similar in all patients, but that of ICP and spTMD differs quite markedly.  
 
Figure 2 Examples of spontaneous tympanic membrane displacement (spTMD), intracranial pressure 
(ICP) and arterial blood pressure (ABP) in patient 2 (left column) and in patient 5 (right column). The 
data has been detrended and shifted to a zero mean. 
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The power spectral densities of patient 5 are shown in Fig. 3. As can be seen, the vast majority of 
power in the signals lies at the frequencies of respiration and heart rate and their harmonics, with 
little power between these frequencies, except at the very low frequencies (0.06 – 0.12 Hz). This is 
typical of the spectra observed in all signals.  
It should be noted that although the 2nd harmonic of respiration was also present in some patients, 
this often coincided with the heart rate and so was indistinguishable in the analysis. As a result, only 
the fundamental and 1st harmonic of respiration, and the heart rate and its 1st harmonic were 
chosen for more detailed analysis. All analysis was undertaken at these individual physiologically 
chosen frequencies, as opposed to a set of fixed frequencies, due to the variation of respiration rate 
and heart rate between patients. 
 
Figure 3 Example power spectral densities (PSD) for patient 5. The PSDs for ABP, ICP, and spTMD are 
plotted. The 4 frequencies of interest are determined (vertical dotted lines with arrows). They are, 
left to right, respiration; respiration 1st harmonic; heart rate; heart rate 1st harmonic. The PSD 
spectra are in arbitrary units to facilitate comparison.  
3.3 Simple Coherence 
The coherence (magnitude squared) plots can be seen for 2 typical patients in Fig. 4. There is clear 
coherence between the pairs of signals at the respiration rate, heart rate, and their harmonics, with 
much less coherence between these frequencies. Despite the high power at the low frequencies 
(0.06 – 0.12 Hz) there appears to be very little coherence at these low frequencies. 
10 
 
Higher harmonics of respiration can also be identified in both patients in Fig. 4. This is only generally 
the case when respiration harmonics frequencies do not coincide with heart rate and its harmonics.  
It should be noted that the respiration rate coherence peaks tend to be sharp due to the use of 
ventilators in 10 out of the 11 patients. 
 
Figure 4 Examples of the coherence (magnitude squared) functions obtained between ABP and 
spTMD, ABP and ICP, and ICP and spTMD, along with the arrows identifying the respiration rate and 
its harmonic, and the heart rate and its harmonic. These are plotted for patients 1 and 5. 
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In general, the coherence between ABP and ICP is greater than for ABP and spTMD, and ICP and 
spTMD. Of more interest in the current work are the coherences between ABP and spTMD and ICP 
and spTMD. On the whole, there is very little difference between these two coherences, with the 
shapes of the coherence plots being very similar (Fig. 4). The mean, median, min and max values of 




  ABP to spTMD ABP to ICP ICP to spTMD Multiple 
Coherence 
Respiration Mean 0.691 0.895 0.663 0.778 
 Median 0.714 0.968 0.714 0.826 
 Min 0.1118 0.5 0.189 0.462 
 Max 0.985 0.993 0.993 0.993 
Respiration 1st 
Harmonic 
Mean 0.355 0.65 0.505 0.598 
 Median 0.373 0.702 0.448 0.519 
 Min 0.033 0.225 0.016 0.06 
 Max 0.751 0.894 0.961 0.978 
Heart Rate Mean 0.924 0.935 0.896 0.943 
 Median 0.984 0.98 0.949 0.987 
 Min 0.466 0.769 0.511 0.614 
 Max 0.998 0.994 0.994 0.998 
Heart Rate 1st 
Harmonic 
Mean 0.851 0.909 0.807 0.872 
 Median 0.928 0.958 0.884 0.941 
 Min 0.084 0.641 0.113 0.165 
 Max 0.995 0.991 0.985 0.995 
Table 2 The mean, median, maximum, and minimum values of the pair-wise coherences (ABP to 
spTMD, ABP to ICP, and ICP to spTMD) and the multiple coherence across the four physiological 
frequencies of interest. Values are derived from 11 patients except for the respiration 1st harmonic 
where only 10 patients displayed a prominent peak.  
In order to show the relative strength of coherences at the 4 physiologically chosen frequencies for 
all patients, Fig. 5 displays the difference in the pair-wise coherence for each patient. The difference 
in coherence is defined as the ICP to spTMD coherence minus the ABP to spTMD coherence – hence 
a positive difference indicates a stronger link for ICP to spTMD transmission and a negative 
difference indicates a stronger link for ABP to spTMD transmission. Given the individual differences 
in respiration frequency and heart rate, the grand-average coherence across the 11 patients would 
not be very meaningful, and so analysis at these four physiologically significant frequencies was 




Figure 5 The difference in coherence between ICP to spTMD and ABP to spTMD at the 4 frequencies 
of interest for the 11 patients. The 1st harmonic of respiration was indiscernible in patient 4 and 
hence not plotted. 
Statistical analysis (Wilcoxon rank-sum tests) comparing the two coherences are given in Table 3, 
together with the number of cases in which this trend was followed.  
 Larger coherence and fraction 
of cases that followed that 
trend 
p 
Respiration ICP to spTMD (7/11) 0.76 
Respiration 1st Harmonic ICP to spTMD  (7/10) 0.11 
Heart Rate ABP to spTMD (9/11) 0.042 
Heart Rate 1st Harmonic ABP to spTMD (9/11) 0.12 
Table 3 The p-value (p) for the difference between the two transmission methods (ABP to spTMD 
and ICP to spTMD) at each frequency of interest. Wilcoxon signed-rank test, α=0.05  
3.4 Multiple Coherence 
The results of the multiple coherence for patient 3 (as an illustrative example) can be seen in Fig. 6. 
The circles indicate the frequencies at which the coherence is not significant. For example, the circle 
at the peak in Fig. 6b) at respiration frequency (left-most arrow) indicates that the multiple 
coherence at this frequency is not significantly larger than with random ABP. However, in Fig. 6c) the 
lack of a circle indicates the multiple coherence is significantly larger than with random ICP. This 
indicates that ICP is providing a significant contribution to spTMD at this frequency, over and above 
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that from ABP, and hence spTMD at the respiration frequency contains more information about the 
ICP than the ABP. As would be expected the randomised spTMD signal gives a very low critical 
coherence indicating that at almost all frequencies ABP and ICP together contribute significantly to 
the spTMD signal. 
 
Figure 6 Multiple coherence estimates for patient 3 (solid lines, identical for the three plots). The 
dotted lines are the 95 % critical coherence generated by 500 repeats of the randomized phase 
signal for: a) spTMD, b) ABP, and c) ICP. A plotted circle indicates that the measured signal does not 
significantly add to the multiple coherence at that frequency. The absence of a plotted circle 
indicates a significant contribution of that signal (beyond that achieved by spectrally equivalent 
random signals) to the multiple coherence. 
Most frequencies have significant multiple coherence for both phase randomised ABP and ICP, i.e. 
both ICP and ABP make (independent) contributions to spTMD. The respiration 1st harmonic (second 
arrow from the left) is one such example in Fig. 6. Inspecting the critical coherence (the dotted line 
in Fig. 6 – defined as the 95th percentile of the distribution of coherence values, from 500 
simulations, for the phase randomised signal) at this frequency, however, shows that the coherence 
for ICP is further from its critical value than that of ABP, suggesting that the former is more highly 
significant, though both are significant contributors to spTMD. The difference between these critical 
coherences is plotted in Fig. 7. As can be seen, at the respiration and respiration 1st harmonic 
frequencies, there is a positive difference in the critical coherence (hence a smaller critical ICP 






and heart rate 1st harmonic, variations in spTMD appear to be driven predominantly by ABP, 
although ICP also explains a large part of the coherence. 
 
Figure 7 Difference in the critical coherences – the dotted line in Fig. 6b) minus the dotted line in Fig. 
6c) – between phase shuffled ABP and phase shuffled ICP for patient 3. A positive value in this 
difference indicates a stronger multiple coherence with the ICP signal than with the ABP signal. 
The difference in the critical coherences – along with the median – is plotted in Fig. 8 for every 
patient. These are plotted at each frequency of interest. Both the respiration and respiration 1st 
harmonic have medians above zero, whilst the heart rate and its harmonic have medians below 
zero. A statistically significant (Wilcoxon rank sum test) non-zero median was found for the 
respiration 1st harmonic (median = 0.10, p = 0.049) and for the heart rate (median = -0.01, p = 0.042). 
It is also apparent that the differences in coherence for most patients are small, as indicated by the 
clustering of results close to the zero difference line (Fig. 8) – which together with the high 




Figure 8 The difference in the critical coherences for each patient at each frequency, along with the 
median value (horizontal bar).  A positive value indicates a greater coherence between the ICP and 
spTMD as opposed to the ABP and spTMD. 
It should be noted here that patient 3 (Fig. 6) is an example where the lowest frequencies (0.06- 0.12 
Hz) also have significant multiple coherence, albeit much lower than those at the spectral peaks. 
Interestingly, the multiple coherence is significant with randomised ICP, but not with randomised 
ABP, indicating that these low frequencies are potentially transmitted from ICP to spTMD. However, 
this is not the case for all patients: only 4/11 of the patients having significant coherence at 
frequencies below the respiratory peak. This does indicate that there may be preferential ICP 
transmission at these low frequencies also, although the limited recording time of the spTMD and 
the potential for low frequency noise due to the drift in the spTMD recording obfuscates this 
observation and does not allow robust generalization. 
 
4. Discussion 
Prior to this study the source of spTMD variations had received little attention beyond rather 
speculative suggestions. In this paper we have quantified the contributions of ICP and ABP to the 
spTMD signal for the first time, and have shown that both ICP and ABP contribute independently to 
the spTMD signal. As well as this, the majority of power in spTMD, in the frequency band studied, 
has been shown to lie at clear physiological frequencies (respiration and its harmonics and heart rate 
and its harmonics), with only much lower coherences (and not always statistically significant) at 
frequencies below respiration, down to the lowest frequencies resolvable (≈0.06 Hz). Analysis of the 
simple coherences between the 2 transmission pathways of interest (ABP to spTMD and ICP to 
spTMD) indicated strong coherences at the above physiological frequencies with little coherence 
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between them, and little significant coherence at the lowest frequencies; again indicating that most 
information lies at the four physiological frequencies chosen. It is likely that low frequency noise 
(including the drift) is contributing to the power observed at the lowest frequencies. Therefore, 
whilst the lowest frequencies are of great interest in the study of the dynamics of ICP and hence in 
spTMD, it was not possible to analyse these with the current data set. 
At respiration and respiration 1st harmonic, there was a preference for the ICP to spTMD pathway 
with 7/11 and 7/10 patients having larger coherences at those frequencies, whereas only 2/11 
patients had a higher ICP to spTMD coherence at heart rate and its 1st harmonic. This indicates that 
ICP is the stronger component at these lower frequencies (although the difference in coherence was 
not significant), whilst at higher frequencies (> 1 Hz) ABP has the greater influence on the spTMD 
signal (significance was demonstrated for the heart rate frequency). This is of interest as it points 
towards the analysis of lower frequencies in the spTMD signal as having less contamination from the 
ABP allowing better potential for extraction of the ICP contributions, and potentially assessment of 
ICP non-invasively. In particular, the spTMD measurements could relate to B-waves or slow waves in 
the low frequency ICP dynamics. Autoregulation is generally considered to be most effective at very 
low frequencies (Czosnyka et al., 2009, Panerai, 2008), and well below the frequencies of the 
oscillations considered in this paper. The preferential transmission of ICP at lower frequencies can be 
explained by considering the cochlear aqueduct as a low-pass filter (Gopen et al., 1997). Gopen et al. 
determined the cut-off of the cochlear aqueduct as being 20 Hz for a fully patent aqueduct, with an 
average diameter and length. However, it is a possibility that the large natural variability in sizes and 
patency of the aqueducts can lead to much smaller frequency cut-offs, and hence only low 
frequency transmission through the cochlear aqueduct, whilst filtering out the heart pulse 
frequencies. 
The simple coherences were corroborated by the multiple coherence analysis, which again 
demonstrated that at lower frequencies the ICP signal had a greater coherence with spTMD than the 
ABP signal – 7/11 and 8/10 patients for the respiration rate and its harmonic. This was reversed at 
the heart rate and its harmonic (both 2/11 patients). When comparing the difference in critical 
coherences between phase shuffling the ICP and ABP (Fig. 8) both the respiration rate and its 
harmonic had a positive median (indicating ICP made a greater contribution), whilst the heart rate 
and its harmonic had a negative median (indicating more information is contained in the ABP). The 
respiration 1st harmonic and heart rate were significantly non-zero, which again points towards the 
analysis of lower frequencies to elucidate the ICP contribution to the spTMD. The sample available 
clearly indicates some inconsistency between individuals and at best trends across the cohort. A 
larger sample may provide more significant results in Table 3, but would not resolve the diversity in 
individual responses. 
The assumed mechanisms of transmission from the ICP to the spTMD and the ABP to the spTMD are 
not straightforward. The main transmission path from ICP to the tympanic membrane is assumed to 
be via the cochlear aqueduct which behaves like a low pass filter transmitting the pressure waves to 
the perilymphatic fluid (Gopen et al., 1997). The perilymphatic fluid then applies a pressure to the 
stapes footplate which transmits the pulsatility across the ossicular chain and displaces the tympanic 
membrane (Marchbanks, 1996). This pathway is not present in those who have an occluded cochlear 
aqueduct (Carlborg et al., 1982). The status of the cochlear aqueduct was unknown in the patients 
we tested. Studies using postural changes and evoked TMD indicated at least 81% of normal healthy 
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subjects of this age range have a patent cochlear aqueduct in at least one ear and that for an 
individual ear, between 63% and 71% of cochlear aqueducts are patent (Campbell-Bell et al., 2017). 
This would imply that between 3 and 4 out of 11 of our patients may have had occluded cochlear 
aqueducts in the ear tested. The ABP pulsatility is transmitted to the ICP via the variations in arterial 
blood volumes in the brain, transmitting the pressure through the brain parenchyma and CSF 
(Wagshul et al., 2011). The direct route from ABP to spTMD is likely due to the vascularisation of the 
outer and middle ear, resulting in a pulsatility that either affects the volume of the ear canal, or is 
directly transferred to the tympanic membrane. The inner ear will also be vascularised and hence 
some of the ABP pulsations may be transmitted via the perilymphatic fluid (Finch et al., 2018). The 
vascular supply to and drainage from the cochlea are both from an intracranial route and are 
therefore themselves a combination of intracranial and arterial pressure waveforms. Due to the 
convoluted transmission pathways, it is likely that the measured ICP and ABP waveforms used in this 
study are modified prior to transmission at the tympanic membrane. However, it is likely such 
modifications will affect the higher frequencies far more than the lower. 
Only the ABP to spTMD and ICP to spTMD pathways were considered in this paper. There will, 
however, be other pathways and physiological signals affecting the spTMD. In particular, venous 
pressures in the ear are likely to be the largest contributor that has not been analysed in this paper. 
Central venous pressure (CVP) can be measured and may be representative of the extracranial 
venous pressures in the ear. In lieu of any such recorded data, the analysis was conducted with only 
the ABP and ICP signals. In future studies we propose to collect CVP along with the other signals; this 
may then also be used as a third input to help clarify its contribution to the spTMD. Another 
potential pathway is the airway pathway through the Eustachian tube to the middle ear causing 
changes in pressure. If the Eustachian tube opens during a recording this can be expected to have a 
profound and dominating impact on the spTMD waveform. However, for the majority of the time, 
and particularly in paralysed ventilated patients, this is likely closed and hence not affecting the 
mechanics of the middle ear. Despite this, the average middle pressure for the patients was – 55 
daPa, which is outside the normal range of -50 to 50 daPa. Such low values are expected in patients 
who have been artificially ventilated. The below average middle ear pressures may have an effect on 
the magnitude of the spTMD, although it is not clear that this is likely to alter the relative 
contributions of ABP and ICP to the TMD waveforms analysed in this study. 
It should be noted that the coherence analysis presented here is a linear technique. Therefore, it will 
not be able to pick up potential non-linear physiological affects between the signals. Considering the 
high levels of coherence observed the linear model appears to provide an acceptable first 
approximation. It should also be pointed out that with strongly periodic signals, the frequency bin-
width in coherence estimation can have a profound effect on the amplitude of peaks in coherence. 
When bins are narrower they will contain less broadband noise while still including most of the 
narrow-band signal power, thus increasing signal-to-noise ratio in each frequency bin and hence 
increasing coherence.  
Finally, our lower frequency range was limited due to the drift in the MMS-14 CCFP analyser, which 
meant the spTMD measurement had to be reset every 20 – 30 seconds. This limited the lower 
frequency range to approximately 0.06 Hz. As a result, low frequencies and static ICP could not be 
analysed. The focus of this work was chosen to be on the higher frequencies; follow on work will 
consider lower frequencies, but given the nature of the recorded signals (epochs with drift), will 
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require a quite distinct approach. A low frequency analysis requires long duration spTMD signals, 
which are reliant on a perfect seal and constant air and ear canal temperature. These conditions are 
extremely difficult to achieve; however, an alternative approach is to extract an spTMD pulse 
amplitude signal from the raw spTMD signal. This would generate a quasi-continuous spTMD pulse 
amplitude signal that is robust across the epochs and affected little by the inherent drift in the 
system, hence allowing investigation of lower frequencies than currently possible. This is of 
particular interest, as this paper has indicated that lower frequencies contain more information 
about the ICP than the ABP. Furthermore, low frequency intracranial pressure waves are known to 
exist and these provide extremely important information on the condition and pathophysiology of 
the brain (Momjian et al., 2004, Spiegelberg et al., 2016).  
Conclusions 
The aim of this paper was two-fold: firstly, to determine whether ICP and ABP are reflected in the 
spTMD signal; secondly, to quantify whether the spTMD signal contained information about the ICP 
above and beyond that found in the ABP. It was found that both the ICP and ABP waveforms are 
transmitted to the spTMD, with both independently contributing to the spTMD. Both signals had a 
very large coherence with the spTMD waveform, and importantly also with one another with little to 
differentiate between them. As a result, we cannot fully separate the relative contributions of ABP 
and ICP. However, the analysis provided a tantalizing suggestion that at lower frequencies (< 1 Hz 
and in particular at the 1st harmonic of respiration) the spTMD tended to contain more information 
about the ICP. At higher frequencies, (> 1 Hz) it appeared that ABP dominated the spTMD signal. As a 
result, it is suggested that future investigation of the spTMD should concentrate on low frequencies 
in order to disentangle the ICP contribution, with the suggestion from our results that at even lower 
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